Janus Henderson Horizon Biotechnology Fund E2 HEUR

WKN A2N852 | ISIN LU1897415292 |  Fonds
Factsheet

Fonds

ISIN Name Performance Volatilität Sharpe Ratio
1 LU2026682919 Candriam Equities L Biotechnology, V2 - Capitalisation +3,74 % +20,67 % 0,08
2 LU0317020203 Candriam Equities L Biotechnology, V - Capitalisation +3,34 % +20,51 % 0,06
3 LU1540961759 HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD +3,02 % +18,69 % 0,05
4 LU0108459040 Candriam Equities L Biotechnology C - Thesaurierung +2,58 % +20,66 % 0,02
5 LU1540962054 HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD +2,49 % +19,52 % 0,02
32 LU1897415292 Janus Henderson Horizon Biotechnology Fund E2 HEUR -4,94 % +27,75 % -0,26
79 LU0767968745 Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating -9,31 % +12,16 % -0,94
80 DE000A3DCA95 BIT Biotech Opportunities S -30,85 % +30,97 % -1,07
81 DE000A3DCBA0 BIT Biotech Opportunities I-II -30,96 % +30,96 % -1,07
82 LU0415392835 Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating -13,32 % +14,06 % -1,10
83 LU0415392595 Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating -13,93 % +14,06 % -1,14